🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the safety and tolerability of ASP...
Status
Completed
Location
Arkansas Children's Hospital Research Institute
Start Date
2019-03-12
Trial ID
NCT03755713
The purpose of this study was to evaluate the safety, efficacy, and immunog...
Status
Completed
Location
Multiple Locations
Start Date
2007-09-24
Trial ID
NCT00543543
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and effect of ulinast...
Status
Unknown
Location
304 hospital of PLA
Start Date
2011-02
Trial ID
NCT01287806
Treatments Being Tested
This study will assess the safety and immunogenicity of GARDASIL®9 (V503) i...
Status
Completed
Location
Universitatsklinik fuer Frauenheilkunde und Geburtshilfe ( Site 0002)
Start Date
2017-09-20
Trial ID
NCT03158220
Treatments Being Tested
Monocentric, observational, descriptive RIPH3 study with prospective data c...
Status
Completed
Location
University Hospital of Toulouse
Start Date
2022-10-10
Trial ID
NCT05534828
Treatments Being Tested
This is a dose-escalation, Phase I/II study evaluating the safety, tolerabi...
Status
Completed
Location
California Research Foundation
Start Date
2023-09-21
Trial ID
NCT05988203
Treatments Being Tested
The purpose of this study is to evaluate vaccine immunogenicity and how wel...
Status
Completed
Location
Multiple Locations
Start Date
2007-10
Trial ID
NCT00551187
This clinical trial will use the amyloid-binding radiotracer, 124I-evuzamit...
Status
Enrolling By Invitation
Location
University of Tennessee Graduate School of Medicine
Start Date
2025-05-22
Trial ID
NCT06907849
Treatments Being Tested
This was a 37-month safety and immunogenicity study conducted in boys and g...
Status
Completed
Location
Multiple Locations
Start Date
2013-12-12
Trial ID
NCT01984697
Treatments Being Tested
Interventional, individually randomized, double (e.g. investigator and part...
Status
Withdrawn
Location
Multiple Locations
Start Date
2016-03
Trial ID
NCT02694952
Treatments Being Tested